Investors sold shares of St. Jude Medical Inc. (NYSE:STJ) on strength during trading on Wednesday. $12.15 million flowed into the stock on the tick-up and $37.88 million flowed out of the stock on the tick-down, for a money net flow of $25.73 million out of the stock. Of all equities tracked, St. Jude Medical had the 0th highest net out-flow for the day. St. Jude Medical traded up $0.03 for the day and closed at $82.21

Several equities analysts have commented on the company. Canaccord Genuity set a $85.00 price objective on St. Jude Medical and gave the company a “hold” rating in a research report on Wednesday, July 20th. Zacks Investment Research downgraded St. Jude Medical from a “buy” rating to a “hold” rating in a report on Friday, July 22nd. Barclays PLC raised their price target on St. Jude Medical from $80.00 to $83.00 and gave the company an “equal weight” rating in a report on Thursday, July 21st. Leerink Swann restated a “hold” rating and set a $85.00 price target on shares of St. Jude Medical in a report on Thursday, July 21st. Finally, Wedbush downgraded St. Jude Medical from an “outperform” rating to a “neutral” rating and raised their price target for the company from $70.00 to $84.00 in a report on Friday, July 15th. Twenty-two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $75.93.

The stock has a 50 day moving average of $78.95 and a 200 day moving average of $65.51. The stock has a market cap of $23.70 billion and a price-to-earnings ratio of 35.74.

St. Jude Medical (NYSE:STJ) last announced its quarterly earnings data on Wednesday, July 20th. The medical technology company reported $1.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.06. The firm earned $1.56 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period in the prior year, the company posted $1.07 earnings per share. The firm’s revenue for the quarter was up 10.8% on a year-over-year basis. Equities analysts predict that St. Jude Medical Inc. will post $4.06 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Stockholders of record on Thursday, June 30th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date is Tuesday, June 28th.

Several hedge funds and institutional investors have recently made changes to their positions in the stock. Schroder Investment Management Group raised its position in shares of St. Jude Medical by 127.2% in the fourth quarter. Schroder Investment Management Group now owns 3,103,759 shares of the medical technology company’s stock worth $191,720,000 after buying an additional 1,737,451 shares in the last quarter. Cornerstone Capital Management Holdings LLC. raised its position in shares of St. Jude Medical by 484.0% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 505,085 shares of the medical technology company’s stock worth $31,198,000 after buying an additional 418,602 shares in the last quarter. Vanguard Group Inc. raised its position in shares of St. Jude Medical by 2.6% in the fourth quarter. Vanguard Group Inc. now owns 16,138,642 shares of the medical technology company’s stock worth $996,883,000 after buying an additional 411,462 shares in the last quarter. Marshall Wace LLP raised its position in shares of St. Jude Medical by 396.9% in the fourth quarter. Marshall Wace LLP now owns 286,788 shares of the medical technology company’s stock worth $17,715,000 after buying an additional 229,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in St. Jude Medical by 32.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 823,890 shares of the medical technology company’s stock valued at $50,894,000 after buying an additional 199,858 shares during the period.

St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.